Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)
Clinical trial NCT03184363 · UNKNOWN
Trial details
- NCT number
- NCT03184363
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2017-10-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.